DEF: American Shared Hospital Services 2026 Proxy Statement

American Shared Hospital Services announces its 2026 Annual Meeting of Shareholders to be held virtually on June 24, 2026.

Summary

• The 2026 Annual Meeting of Shareholders will be held virtually on June 24, 2026, at 9:00 a.m. Central Daylight Time.
• Shareholders will vote on the election of four directors: Daniel G. Kelly, Jr., Kathleen Miles, Raymond C. Stachowiak, and Vicki L. Wilson.
• The meeting includes an advisory vote on executive compensation and a proposal to amend and restate the Incentive Compensation Plan to extend its term by five years to February 22, 2032.
• Shareholders will ratify the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for 2026.
• As of the April 27, 2026 record date, there were 6,627,466 common shares issued and outstanding.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing; while it provides necessary governance updates and plan extensions, the recent sudden resignation of the CEO introduces uncertainty.

Positives

• Approximately 97% of votes cast at the 2025 Annual Meeting were in favor of the executive compensation program.
• The company maintains a compensation recoupment policy compliant with SEC and NYSE American rules.
• Directors and executive officers hold a significant equity stake (approximately 24.4%), aligning their interests with shareholders.
• The company has successfully transitioned to a new independent auditor, Baker Tilly US, LLP.

Negatives

• The company experienced significant leadership turnover, including the resignation of CEO Gary Delanois on April 24, 2026, for personal reasons.
• Performance-based compensation targets under the Variable Compensation Plan (VCP) were not met in 2025, resulting in no bonuses for named executive officers.
• The company has faced recent volatility in executive leadership roles.

Risks

• The company is dependent on the performance of its medical equipment services, including Gamma Knife and proton beam radiation therapy.
• The company faces potential dilution from the Incentive Compensation Plan, which has approximately 408,000 shares remaining for future awards.
• The company is subject to risks associated with the loss of key personnel and the ability to attract and retain qualified leadership.
• The company's financial performance is subject to market conditions and the ability to secure new client agreements.

Future Outlook

The company intends to continue its focus on providing Gamma Knife and other medical services to hospitals in the U.S. and internationally, while expanding its proton beam radiation therapy services. The company is seeking to extend its Incentive Compensation Plan to 2032 to continue attracting and retaining key talent.

Management Comments

• The Board believes the most effective leadership structure is to keep the roles of Executive Chairman and CEO separate.
• The Board is committed to excellence in governance and believes the executive compensation program is reasonable and effective in aligning interests with shareholders.
• The company is committed to using equity incentive awards prudently and within reasonable limits.

Industry Context

StockSavvy.ai notes that the company is navigating a challenging period of leadership transition within the specialized medical equipment services sector, which requires stable governance to maintain client trust and operational continuity.

Comparison to Industry Standards

• The company's compensation practices, including the lack of guaranteed salary increases and the use of performance-based gates, align with standard corporate governance practices for smaller reporting companies.
• The use of an independent compensation committee and the adoption of a clawback policy are consistent with current NYSE American listing standards.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed.

Related Party Transactions

• None disclosed since January 1, 2024.

Stakeholder Impact

• Shareholders are asked to vote on key governance and compensation matters.
• Employees and executives are subject to the terms of the amended Incentive Compensation Plan.
• The leadership transition may impact operational stability for customers and partners.

Next Steps

• Hold the 2026 Annual Meeting of Shareholders on June 24, 2026.
• Execute the amendment and restatement of the Incentive Compensation Plan if approved.
• Continue the search for a permanent CEO following the resignation of Gary Delanois.

Key Dates

Recommendation

The company is in a period of leadership transition with the recent appointment of an interim CEO. Investors should wait for clarity on the long-term strategic direction and the appointment of a permanent CEO before increasing positions.

Keywords

American Shared Hospital Services, AMS, Proxy Statement, Incentive Compensation Plan, Corporate Governance, Executive Compensation, Medical Services